None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.aged 18 - 85 years; 2.Neurovascular interventional procedure was planned; 3.Signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.The patient has undergone surgery or interventional therapy within 1 month; 2.The patient had a subarachnoid hemorrhage or intracranial hemorrhage within 2 months; 3.The patient has had active ulceration within 6 months; 4.The patient has a bleeding tendency disease or coagulation dysfunction, such as preoperative platelet count 180 / 100mmHg or BP <90 / 60mmHg); 6.The target aneurysm is a blood blister-like aneurysm, dissecting aneurysm, infectious aneurysm, or ruptured aneurysm; 7.Severe intracranial vascular tortuosity is not amenable to interventional therapy; 8.Suffering from cognitive impairment; 9.Pregnant or lactating females; 10.Ongoing participation in other clinical trials; 11.There are other contraindications to surgery (such as Severe allergy to anticoagulant/antiplatelet drugs, anesthetic drugs, contrast agents or Acute myocardial infarction, etc); 12.It is judged by the investigator to be unsuitable for inclusion in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Device success; | — |
Secondary
| Measure | Time frame |
|---|---|
| Acute procedure success;The incidence of adverse events;The incidence of serious adverse events;Device defects; | — |
Countries
China
Contacts
Yichang Central People's Hospital